Abstract

We thank Nicholas Evans for his comments (1). There has been much recent discussion of how best to balance the public health needs of mitigating the impact of emerging infectious diseases with the concerns of biosafety and biosecurity that dual-use research entails (2–4). In our recent article (5), we sought to inform this discussion from the perspective of the dynamic nature of influenza viruses themselves. Our goal was to describe how influenza virus evolution, with regard to alterations in virulence, host switching, antigenic drift, and development of antiviral resistance, etc., could be examined metaphorically through the lens of the promulgated dual-use rules (6). Further, it was our contention that a better understanding of the variable and everchanging genotypic and phenotypic properties of influenza A viruses in nature would be helpful as a platform to better inform future policy decisions aimed at balancing important public health and biosafety/biosecurity concerns.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.